Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia.

MLA

Mehraban Far, Parsa, et al. “Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia.” Ocular Immunology & Inflammation, vol. 30, no. 4, July 2022, pp. 1005–08. EBSCOhost, https://doi.org/10.1080/09273948.2020.1841802.

APA

Mehraban Far, P., Rullo, J., Farmer, J., & Urton, T. (2022). Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia. Ocular Immunology & Inflammation, 30(4), 1005–1008. https://doi.org/10.1080/09273948.2020.1841802

Chicago

Mehraban Far, Parsa, Jacob Rullo, James Farmer, and Todd Urton. 2022. “Recurrent Uveitis Related to Ibrutinib for Treatment of Chronic Lymphocytic Leukemia.” Ocular Immunology & Inflammation 30 (4): 1005–8. doi:10.1080/09273948.2020.1841802.